Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era

BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing. Development of newer therapeutic modalities has changed the paradigm of HCC treatment in recent years. So, the aim of our study is to analyze the impact of these treatment modalities into the survival of HCC patients, based o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Gastrointest Oncol
Päätekijät: Shah, Chintan, Mramba, Lazarus K., Bishnoi, Rohit, Bejjanki, Harini, Chhatrala, Hardik Satish, Chandana, Sreenivasa R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674257/
https://ncbi.nlm.nih.gov/pubmed/29184682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.16
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia